US Patent Issued to General Probiotics on June 2 for "Combinations of engineered antimicrobial probiotics for treatment of gastrointestinal tract pathogens" (Minnesota Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,826, issued on June 2, was assigned to General Probiotics Inc. (St. Paul, Minn.).

"Combinations of engineered antimicrobial probiotics for treatment of gastrointestinal tract pathogens" was invented by Yiannis John Kaznessis (New Brighton, Minn.), Kathryn Gayle Kruziki (New Brighton, Minn.) and Dimitrios Nikolaos Sidiropoulos (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments herein relate to engineered antimicrobial probiotics for the treatment of gastrointestinal tract pathogens. In an embodiment, a composition for treatment of an animal is included. The composition can include a first genetically engineered bacterium comprisin...